Clinical Trial Update: Multimodal Brain Imaging of Methylphenidate in Children and Adolescents With ADHD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating multimodal brain imaging of methylphenidate in children and adolescents with ADHD has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Johns Hopkins University | Conditions: ADHD | Phase 4 | Status: WITHDRAWN